ML-SYS / 2026.07NON-CLINICAL RESEARCH MATERIALSORIGIN DECLARED BY LOT

← Compound index

RM-MET / Metabolic and incretin signalling

Adipotide

Also known as: FTPP · Prohibitin-targeting peptidomimetic · CKGGRAKDC-GG-D(KLAKLAK)2

Preclinical evidenceEvidence grade C: Preclinical evidence

Grade describes the published research on the molecule. It is not a quality score, a safety score, or a release state.

What this is

Adipotide is a composite peptidomimetic that couples a vascular-homing motif to a pro-apoptotic sequence. Exact sequence, D-amino-acid notation and conjugate integrity are part of its identity.

Evidence position

The frequently cited record is a controlled non-human-primate study. It supports a preclinical grade, not a human-evidence grade.

What the record does not establish

Animal weight or insulin findings do not establish human effectiveness, a safe exposure range, or the identity and purity of a separately sourced sample.

Sources

  • 01
    Adipotide study in obese monkeysPubMed
    Shows
    Non-human-primate study of targeted adipose-vascular apoptosis, body composition and insulin sensitivity
    Does not show
    Animal study with reversible renal proximal-tubule changes; not human evidence or a supplier-lot test

External database index

LIVE DATABASE INDEX / SEPARATE FROM CURATED EVIDENCE

Records below come directly from public scientific databases. They help find relevant material, but do not affect the evidence grade until they are matched to the molecule and added to the curated source list.

PUBMED / FOUND RECORDS

  1. A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.Science translational medicine / 2011 Nov 9PMID 22072637 / DOI 10.1126/scitranslmed.3002621
  2. A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication.Journal of controlled release : official journal of the Controlled Release Society / 2013 Oct 28PMID 23871959 / DOI 10.1016/j.jconrel.2013.07.013
  3. Comment on "a peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys".Science translational medicine / 2012 Apr 25PMID 22539771 / DOI 10.1126/scitranslmed.3003760

Related compounds